DNA

SQUID pries open AI black box

COLD SPRING HARBOR, N.Y., June 21, 2024 /PRNewswire/ -- Artificial intelligence continues to squirm its way into many aspects of…

2 years ago

University of Vermont Health Network and the Center for Donation & Transplant Launch InVita Healthcare Technologies’ iReferral to Streamline the Organ and Tissue Donation Referral Process

iReferralSM automatically identifies potential organ and tissue donors and streamlines the hospital-to-OPO referral process. BURLINGTON, Vt., June 20, 2024 /PRNewswire/ --…

2 years ago

NORTHWELL HEALTH AND THE GALIEN FOUNDATION ANNOUNCE COLLABORATION TO SUPPORT GLOBAL HEALTHCARE INNOVATORS

Collaboration Launches with Opportunity for Prix Galien Award Winners from Around the World to Get Access to Northwell Health's International…

2 years ago

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT…

2 years ago

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s…

2 years ago

Konica Minolta Healthcare and Christie Innomed Partner to Provide Healthcare IT Sales and Services in the US

Exa Platform Konica Minolta Healthcare’s Exa® Platform is a software solution comprised of PACS, RIS and Billing modules for managing…

2 years ago

New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows

BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc.’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in…

2 years ago

LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

UTRECHT, The Netherlands and PHILADELPHIA, June 20, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company focused on…

2 years ago

Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development

Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on…

2 years ago

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

2 years ago